Statins: A potential role in the management of osteoarthritis?

被引：30

作者：

Baker, Joseph F. ^{[1
,2
]}

Walsh, Pauline ^{[2
]}

Mulhall, Kevin J. ^{[1
]}

机构：

[1] Mater Misericordiae Univ Hosp, Dept Trauma & Orthopaed Surg, Dublin 7, Ireland

[2] Catherine McAuley Ctr, UCD Clin Res Unit, Dublin 7, Ireland

来源：

JOINT BONE SPINE | 2011年 / 78卷 / 01期

关键词：

Statins; Osteoarthritis; NITRIC-OXIDE SYNTHASE; COLLAGEN-INDUCED ARTHRITIS; C-REACTIVE PROTEIN; MATRIX METALLOPROTEINASES; POLYMORPHONUCLEAR LEUKOCYTES; REDUCTASE INHIBITORS; THERAPEUTIC TARGETS; ARTICULAR-CARTILAGE; HIP OSTEOARTHRITIS; ENDOTHELIAL-CELLS;

D O I：

10.1016/j.jbspin.2010.02.035

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Osteoarthritis is a degenerative joint disease frequently encountered in rheumatologic and orthopaedic practice. It is a progressive disease that currently available pharmacological therapy can only control the symptoms of. Non-steroidal anti-inflammatory drugs, the most preferred drug by patients, have significant side effects and the end stage treatment of osteoarthritis, in the form of joint replacement surgery, carries inherent risks to the patient. We review the potential role of statins, a drug class developed for and widely used in the treatment of hypercholesterolaemia. It is becoming clear that these drugs have more than just cholesterol lowering properties and we provide an up to date assessment of the work carried out to target osteoarthritis with these agents. (C) 2010 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

引用

页码：31 / 34

页数：4

共 63 条

[1]

Statins as antiinflammatory and immunomodulatory agents - A future in rheumatologic therapy? [J].

Abeles, AM ;

Pillinger, MH .

ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :393-407

[2]

Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis [J].

Abramson S.B. ;

Attur M. ;

Amin A.R. ;

Clancy R. .

Current Rheumatology Reports, 2001, 3 (6) :535-541

[3]

Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation [J].

Akasaki, Y. ;

Matsuda, S. ;

Nakayama, K. ;

Fukagawa, S. ;

Miura, H. ;

Iwamoto, Y. .

OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (02) :235-243

[4]

[Anonymous], ARTHRITIS RHEUM

[5]

Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients [J].

Ascer, E ;

Bertolami, MC ;

Venturinelli, ML ;

Buccheri, V ;

Souza, J ;

Nicolau, JC ;

Ramires, JAF ;

Serrano, CV .

ATHEROSCLEROSIS, 2004, 177 (01) :161-166

[6]

Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine [J].

Attur, MG ;

Dave, M ;

Akamatsu, M ;

Katoh, M ;

Amin, AR .

OSTEOARTHRITIS AND CARTILAGE, 2002, 10 (01) :1-4

[7]

Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis [J].

Barsante, MM ;

Roffê, E ;

Yokoro, CM ;

Tafuri, WL ;

Souza, DG ;

Pinho, V ;

Castro, MSD ;

Teixeira, MM .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 516 (03) :282-289

[8]

Beattie MS, 2005, J RHEUMATOL, V32, P106

[9]

Osteoarthritis, angiogenesis and inflammation [J].

Bonnet, CS ;

Walsh, DA .

RHEUMATOLOGY, 2005, 44 (01) :7-16

[10]

Is progressive osteoarthritis an atheromatous vascular disease? [J].

Conaghan, PG ;

Vanharanta, H ;

Dieppe, PA .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (11) :1539-1541

← 1 2 3 4 5 6 7 →